Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: International guidelines recommend dopamine or norepinephrine as first-line vasopressor agents in septic shock. Phenylephrine, epinephrine, vasopressin and terlipressin are considered second-line agents. Our objective was to assess the evidence for the efficiency and safety of all vasopressors in septic shock. METHODS: Systematic review and meta-analysis. We searched electronic database of MEDLINE, CENTRAL, LILACS and conference proceedings up to June 2014. We included randomized controlled trials comparing different vasopressors for the treatment of adult patients with septic shock. Primary outcome was all-cause mortality. Other clinical and hemodynamic measurements were extracted as secondary outcomes. Risk ratios (RR) and mean differences with 95% confidence intervals (CI) were pooled. RESULTS: Thirty-two trials (3,544 patients) were included. Compared to dopamine (866 patients, 450 events), norepinephrine (832 patients, 376 events) was associated with decreased all-cause mortality, RR 0.89 (95% CI 0.81-0.98), corresponding to an absolute risk reduction of 11% and number needed to treat of 9. Norepinephrine was associated with lower risk for major adverse events and cardiac arrhythmias compared to dopamine. No other mortality benefit was demonstrated for the comparisons of norepinephrine to epinephrine, phenylephrine and vasopressin / terlipressin. Hemodynamic data were similar between the different vasopressors, with some advantage for norepinephrine in central venous pressure, urinary output and blood lactate levels. CONCLUSIONS: Evidence suggests a survival benefit, better hemodynamic profile and reduced adverse events rate for norepinephrine over dopamine. Norepinephrine should be regarded as the first line vasopressor in the treatment of septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the absence of septic shock or fungemia, some implanted tunneled catheter infections may be treated effectively with prolonged antimicrobial therapy if removal of the catheter is not practical (273).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [273]
Experimental — accuracy not yet measuredIn the citing paper
“In a systematic review and meta-analysis of 11 RCTs, norepinephrine resulted in a lower mortality (RR 0.89; 95% CI 0.81–0.98) and lower risk of arrhythmias (RR 0.48; 95% CI 0.40–0.58) compared with dopamine [347].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · cited 1×
“5 ml/kg/hr within 6 hours of initiation of therapy [5].”
BackgroundEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 1×
“Septic shock accounts for about 9% of admissions, and is the most common cause of death in intensive care units (ICUs) [1,2].”
BackgroundSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 2×
“The Surviving Sepsis Campaign recommends norepinephrine or dopamine as the first-choice vasopressor agent followed by epinephrine in patients who respond poorly to dopamine or norepinephrine [7,8].”
BackgroundA randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414 · cited 6×
“The concept of early goal directed therapy was challenged recently in a large RCT [43], in which no mortality benefit with protocol based resuscitation was observed compared with usual care.”
BackgroundInfluentialComparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940 · cited 5×
“triple blinded [15], 8 trials were double blinded [13, 24, 26, 27, 30–32, 36], 2 were single blinded [20, 34] and the others were open-labeled or not stated.”
BackgroundResultInfluentialVasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Research works printed but not linked: 3
- Chen H, Zeng Z (2012) Comparisom of the effect and complication between dopaimne and norepinephrine on treatment of the septic shock. Jiangxi Medical Journal 47: 565– 567.
- High K (2008) Impact of Dopamine and norepinephrine on renal perfusion in patients with septic shock. Journal of Hebei Medicine 30: 1188– 1121.
- Zhuangyu Y (2011) Affect of norepinephrine and dopamine on infectious tissue oxygen metabolism and hemodynamics in patients with shock. Shandong Medicine Journal 51: 93– 94.
Cited by
Items 101–200 of 293
Boekhoud, L., Schaap, H. M. E. A., Huizinga, R. L., Olgers, T. J., ter Maaten, J. C., Postma, D. F., & Bouma, H. R. (2024) · Infection · doi:10.1007/s15010-024-02247-4 · Cited by 15
Current Controversies in Sepsis Management
Moss, S. R., & Prescott, H. C. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1696981 · Cited by 15
Wayland, J., Teixeira, J. P., & Nielsen, N. D. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.06.010 · Cited by 23
Jha, A., Zilahi, G., & Rhodes, A. (2021) · BJA Education · doi:10.1016/j.bjae.2021.03.002 · Cited by 18
The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock
Hamzaoui, O., Goury, A., & Teboul, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144589 · Cited by 17
“This recommendation was based on the results of a randomized controlled trial (RCT) showing less cardiac arrhythmia with norepinephrine compared with dopamine [8] and on meta-analyses showing less mortality and less cardiac arrhythmia with norepinephrine [9,10].”
ResultGetu, S. A., Legese, G. L., Gashu, K. D., Ayalew, D. G., & Amare, T. (2024) · BioMed Research International · doi:10.1155/2024/4378635 · Cited by 13
“But it is in line with the studies conducted else-where [7, 37, 38].”
ResultVasopressor effects on venous return in septic patients: a review
Feldheiser, A., Gelman, S., Chew, M. S., & Stopfkuchen-Evans, M. F. (2021) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001508 · Cited by 15
Suzuki, R., Uchino, S., Sasabuchi, Y., Lefor, A. K., & Sanui, M. (2022) · Critical Care · doi:10.1186/s13054-022-03960-y · Cited by 16
“Subsequent studies, however, refuted the bene cial effects of dopamine on patient-centered outcomes in the contexts of renal protection (2-6) and as a vasopressor (7-10).”
ResultSedhai, Y. R., Shrestha, D. B., Budhathoki, P., Memon, W. A., Acharya, R., Gaire, S., Pokharel, N., Maharjan, S., Jasaraj, R. B., Sodhi, A., et al. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202203.005 · Cited by 18
“A previous meta-analysis had also reached a similar conclusion [28].”
ResultNorepinephrine versus Dopamine for Septic Shock in Neonates: A Randomized Controlled Trial
Mazhari, M. Y. A., Priyadarshi, M., Singh, P. K., Chaurasia, S., & Basu, S. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114599 · Cited by 13
50 Years of Sepsis Investigation/Enlightenment Among Adults—The Long and Winding Road
Dellinger, R. P., Levy, M. M., Schorr, C., & Townsend, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005203 · Cited by 12
Review article: Sepsis in the emergency department – Part 3: Treatment
Williams, J. M., Keijzers, G., Macdonald, S. P. J., Shetty, A., & Fraser, J. F. (2018) · Emergency Medicine Australasia · doi:10.1111/1742-6723.12951 · Cited by 13
Norepinephrine-Induced Peripheral Ischemia Leading to Gangrene: A Case Series
Wilson, M., Schafer, K., Goldschmidt, E., Wu, B., & Simman, R. (2021) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000741528.49437.2c · Cited by 11
“Aprimarilyα-adrenergicmedicationwith β-adrenergic properties, norepinephrine is currently the vasopressor of choice for acute circulatory failure given its reduced all-cause mortality and lower rate of adverse events comparedwith other pressors.(1,2) However, because it exerts its effects via peripheral vasoconstricti…”
BackgroundKilcommons, S. J., Hammal, F., Kamaleldin, M., Opgenorth, D. L., Fiest, K. M., Karvellas, C. J., Kutsogiannis, D. J., Lau, V. I., MacIntyre, E. J., Rochwerg, B. N., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006519 · Cited by 13
“This is an intriguing finding as previous studies evaluating the use of differing vaso-pressors have not revealed an effect on mortality (48– 50).”
Fármacos vasoactivos en el tratamiento del shock séptico
Andaluz‐Ojeda, D., Cantón‐Bulnes, M. L., Richter, C. P., & Garnacho‐Montero, J. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.03.001 · Cited by 26
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
Albertson, T. E., Chenoweth, J., Lewis, J., Pugashetti, J. V., Sandrock, C. E., & Morrissey, B. M. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2110067 · Cited by 13
Li, Z., & Xing, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1323721 · Cited by 11
Relaxed Parameter Sharing: Effectively Modeling Time-Varying Relationships in Clinical Time-SeriesPreprint
Oh, J., Wang, J., Tang, S., Sjoding, M. W., & Wiens, J. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1906.02898 · Cited by 16
“Onset time of shock was determined by the earliest administration of vasopressors (Avni et al., 2015).”
MethodManaging Adult Acute and Acute-on-Chronic Liver Failure in the ICU
Han, X., Davis, A. M., & Parker, W. F. (2021) · JAMA · doi:10.1001/jama.2021.12742 · Cited by 10
Zhu, B., Jiang, J., Yu, H., Huang, L. J., & Zhou, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-52514-5 · Cited by 12
“An early review 19 showed that norepinephrine had an advantage over dopamine in all-cause mortality and the development of arrhythmias in septic shock.”
BackgroundZhou, D., Zhu, B., Jiang, J., Zhou, G., & Zhou, S. (2020) · Medical Science Monitor · doi:10.12659/msm.927716 · Cited by 12
Wentowski, C. C., Inglés, D. P., & Nielsen, N. D. (2021) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2021.10.001 · Cited by 15
Konjety, P., & Chakole, V. (2024) · Cureus · doi:10.7759/cureus.64249 · Cited by 19
Survival prediction for heart failure complicated by sepsis: based on machine learning methods
Zhang, Q., Xu, L., He, W., Lai, X., & Huang, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1410702 · Cited by 12
McDonald, R., Burns, M., Wong, A., Smith, C., Ostermann, M., & Hutchings, S. (2025) · Critical Care · doi:10.1186/s13054-025-05573-7 · Cited by 9
“To date, most systematic reviews investigating the effects of different vasopressors in septic shock have focussed on mortality [10–18].”
Der-Nigoghossian, C. A., Hammond, D. A., & Ammar, M. A. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020901521 · Cited by 13
Perioperative hypotension and use of vasoactive agents in non‐cardiac surgery: A scoping review
Bækgaard, E. S., Madsen, B. K., Crone, V., El‐Hallak, H., Møller, M. H., Vester‐Andersen, M., & Krag, M. (2024) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14485 · Cited by 12
Effect of non-adrenergic vasopressors on macro- and microvascular coupling in distributive shock
Heßler, M., Kampmeier, T., & Rehberg, S. W. (2016) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2016.10.010 · Cited by 9
Fatores de risco para morte em pacientes com sepse em uma unidade de terapia intensiva
do Prado, P. R., Volpáti, N. V., Gimenes, F. R. E., Atila, E. G., Maggi, L. E., & Amaral, T. L. M. (2018) · Rev Rene · doi:10.15253/2175-6783.2018193231 · Cited by 9
Optimal Management of Hypotension During Cesarean Delivery Under Spinal Anesthesia
Fichter, J., & Nelson, K. E. (2019) · Advances in Anesthesia · doi:10.1016/j.aan.2019.08.008 · Cited by 9
Modern Vasopressor Therapy of Septic Shock (Review)
Kochkin, А. А., Yavorovskiy, A. G., Бондоевич, Б. Л., & Likhvantsev, V. V. (2020) · General Reanimatology · doi:10.15360/1813-9779-2020-2-77-93 · Cited by 11
“Кроме этого, выбор НА в качестве препарата первой линии связан с меньшим риском возникновения аритмий [42], и ассоциирован с более низкой летальностью, в сравнении с допамином [40, 42], что подтверждается исследованием Avni T.”
BackgroundResultInfluentialMaximous, S. I., Brotherton, B. J., Achilleos, A., Akrami, K., Barros, L. M., Cobb, N. L., Misango, D., Papali, A. C., Park, C., Shetty, V. U., et al. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-1105 · Cited by 10
“21).(61) In addition, there was no difference in mortality between norepinephrine and phenylephrine (RR: 0.”
BackgroundBerry, M. T., Patel, B. V., & Brett, S. J. (2017) · Drugs · doi:10.1007/s40265-017-0698-0 · Cited by 10
“No statistically significant improvement in mortality was observed in a comparison between vasopressin and adrenergic vasopressors (noradrenaline, dopamine), although an overall trend towards reduced mortality with noradrenaline was seen in all comparisons [41, 45].”
BackgroundVasopressor and inotrope treatment for septic shock: An umbrella review of reviews
Einav, S., Helviz, Y., Ippolito, M., & Cortegiani, A. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.05.017 · Cited by 10
Bauer, S. R., Wieruszewski, P. M., Bissell, B. D., Dugar, S. P., Sacha, G. L., Sato, R., Siuba, M., Schleicher, M. C., Vachharajani, V., Falck-Ytter, Y. T., et al. (2025) · Shock · doi:10.1097/shk.0000000000002558 · Cited by 9
Kalamar, Ž., Gorenjak, M., Landoni, G., & Markota, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331304 · Cited by 10
“A meta-analysis of thirty-two trials comparing epinephrine, phenylephrine and vasopressin or terlipressin to norepinephrine showed no survival benefit [42].”
Recent advances in ROS-modulating materials for sepsis treatment
Mo, X. W., Min, D. K., & Kim, J. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114779 · Cited by 9
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock
Mergoum, A. M., Rhone, A., Larson, N. J., Dries, D. J., Blondeau, B., & Rogers, F. B. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241246230 · Cited by 11
“28 Norepinephrine is usually started at a dose between 0.01 and 0.05 µg/kg/min, which may be titrated up at increments of 0.02 to 0.04 µg/kg/ min every 5 to 15 minutes until the MAP goal of 65 mm Hg or greater is reached.”
InfluentialMoran, J. L., & Graham, P. L. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.06.003 · Cited by 8
Kohn-Loncarica, G. A., Fustiñana, A. L., Santos, C., Lantelli, G. P., Rowensztein, H., & González‐Dambrauskas, S. (2020) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20200092 · Cited by 8
“(13) In adults, a recent meta-analysis concluded that there is a benefit related to survival, the rate of adverse effects, and the hemodynamic profile with the use of epinephrine over dopamine in patients with septic shock.(17) In adult patients, higher mortality and more frequent development of cardiac arrhythmias we…”
BackgroundBelletti, A., Azzolini, M. L., Baldetti, L., Landoni, G., Franco, A., & Zangrillo, A. (2022) · General Reanimatology · doi:10.15360/1813-9779-2022-5-60-77 · Cited by 8
Advances in Vasodilatory Shock: A Concise Review
Thakur, S. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23266 · Cited by 11
Carsetti, A., Bignami, E., Cortegiani, A., Donadello, K., Donati, A., Foti, G., Grasselli, G., ROMAGNOLI, S., Antonelli, M. M., Blasio, E. D., et al. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14866-1 · Cited by 8
Potentially Preventable Deaths by Intensive Care Medicine in Mongolian Hospitals
Mendsaikhan, N., Begzjav, T., Lundeg, G., & Dünser, M. W. (2016) · Critical Care Research and Practice · doi:10.1155/2016/8624035 · Cited by 12
“Accordingly, interventions known to save lives in critically ill patients, such as mechanical ventilation [6], vasopressor therapy [7], or renal replacement therapy [8], were set in only a comparatively small amount of study patients dying in the ICU.”
BackgroundKyriazopoulou, E., & Giamarellos‐Bourboulis, E. J. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1589451 · Cited by 7
Kasugai, D., Nishikimi, M., Nishida, K., Higashi, M., Yamamoto, T., Numaguchi, A., Takahashi, K., Matsui, S., & Matsuda, N. (2019) · Journal of Intensive Care · doi:10.1186/s40560-019-0377-1 · Cited by 8
Cirrhosis Management in the Intensive Care Unit
Smith, T. N., de Moraes, A. G., & Simonetto, D. A. (2023) · Seminars in Liver Disease · doi:10.1055/a-2015-1290 · Cited by 8
Hotspot Analysis of Sepsis Literature
Xu, C., Wang, Z., Lu, K., & Jin, H. (2018) · Medical Science Monitor · doi:10.12659/msm.908950 · Cited by 7
“For example, the use of norepinephrine was found to lead to a lower mortality and lower risk of arrhythmia compared to the use of dopamine [48].”
BackgroundUse of vasopressin in the treatment of refractory septic shock
Kny, K. T., Ferreira, M. A. P., & Pizzol, T. D. S. D. (2018) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20180060 · Cited by 7
“,(24) the effect of different vasopressors on the total mortality of adult patients with septic shock was evaluated.”
BackgroundUpdates in the Management of Perioperative Vasoplegic Syndrome
Brennan, K. M., Bhutiani, M., Kingeter, M. A., & McEvoy, M. D. (2022) · Advances in Anesthesia · doi:10.1016/j.aan.2022.07.010 · Cited by 8
Ceausu, D., Boulet, N., Roger, C., Alonso, S., Lefrant, J., Boisson, C., Mura, T., & Muller, L. (2024) · Shock · doi:10.1097/shk.0000000000002454 · Cited by 7
“NE is the most widely used vasopressors in ICU, with demonstrated benefits over dopamine (2,14) and epinephrine (15).”
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.02.003 · Cited by 9
Class-Modeling of Septic Shock With Hyperdimensional Computing
Watkinson, N., Givargis, T., Joe, V., Nicolau, A. E., & Veidenbaum, A. V. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9630353 · Cited by 8
“There are different proposed guidelines regarding when vasopressor usage should begin – the earliest suggested starting time being simultaneous to fluid resuscitation in response to hypotension [4], [5].”
BackgroundAntonucci, E., Giovini, M., Agosta, S., Sakr, Y. L., & Léone, M. (2022) · Shock · doi:10.1097/shk.0000000000001932 · Cited by 9
“Furthermore, a systemic review and meta-analysis (20) including 32 studies showed no mortality benefit when NE and epinephrine were compared in four RCTs.”
BackgroundVasopressin vs noradrenaline: Have we found the perfect recipe to improve outcome in septic shock?
Chidambaram, S., Goh, E. L., Rey, V. G., & Khan, M. A. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.10.029 · Cited by 7
Sarmiento, J. F. (2022) · Acta Pediátrica de México · doi:10.18233/apm.v43i1.2480 · Cited by 11
Management of Sepsis in the Pediatric Patient
Rooney, S. P., Heffren, J. C., Song, B. L., & Sanchez, A. C. (2019) · Journal of Radiology Nursing · doi:10.1016/j.jradnu.2019.07.009 · Cited by 5
Vasodilatory Shock in the ICU: Perils, Pitfalls and Therapeutic Options
Vallabhajosyula, S., Jentzer, J. C., & Khanna, A. K. (2018) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-73670-9_9 · Cited by 5
Pharmacologic Agents for the Treatment of Vasodilatory Shock
Knotzer, H., Poidinger, B., & Kleinsasser, A. T. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190704101907 · Cited by 5
Application of norepinephrine in the treatment of septic shock: a meta-analysis
Xu, Q., Jin, Y., Fu, L., & Li, Y. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03827-x · Cited by 7
“It was similar to the conclusion reported in two reviews [27, 28], where norepinephrine was superior to dopamine in a 28-day mortality rate.”
Kumar, R., Chowdhury, J. B., & Jain, R. K. (2001) · PubMed · Cited by 7
Li, D., & Du, W. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000238 · Cited by 4
Evidence for the Application of Sepsis Bundles in 2021
Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733899 · Cited by 4
Sardaneh, A. A., Penm, J. H.-D., Oliver, M., Gattas, D. J., McLachlan, A. J., & Patanwala, A. E. (2021) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2021-003035 · Cited by 5
Refractory anaphylaxis: further considerations for emergency care providers
Alqurashi, W., Alnaji, F., & Menon, K. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.12.028 · Cited by 4
The Clinical Conundrum of Vasoplegia With Mechanical Circulatory Support Devices
Mehra, M. R., & Castagna, F. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100914 · Cited by 4
Impact of tadalafil on cardiovascular and organ dysfunction induced by experimental sepsis
Nakashima, M. A., Delfrate, G., Albino, L. B., Alves, G. F., Oliveira, J. G., & Fernandes, D. (2025) · Acute and Critical Care · doi:10.4266/acc.002904 · Cited by 4
Yokokawa, Y., Sakurai, R., Kudo, D., Tamiya, G., & Kushimoto, S. (2026) · Critical Care · doi:10.1186/s13054-025-05819-4 · Cited by 3
“…Guidelines for Management of Sepsis and Septic Shock [2, 3] recommend initial fluid resuscitation [4], early administration of appropriate antimicrobials [5, 6], and administration of vasopres-sors for septic shock [7] as part of the treatment bundle to be initiated within one hour of recognition.”
Intraoperative Hypotension and Vasoactive Treatment: An International Survey of Anaesthesiologists
Bækgaard, E. S., Vester‐Andersen, M., Crone, V., Møller, M. H., Yamanaka, S., Pálmarsdóttir, R., Uusalo, P., Haidl, F., Rådestad, M., van der Sloot, K., et al. (2026) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.70197 · Cited by 3
Tripathi, M. K., Padhy, S. S., Malviya, D., Harjai, M., Das, P., & Rastogi, S. (2020) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_83_20 · Cited by 3
Navigating the Labyrinth: Intensive Care Challenges for Patients with Acute-on-Chronic Liver Failure
Saner, F. H., Raptis, D. A., Alghamdi, S. A., Malagó, M., Broering, D., & Bezinover, D. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020506 · Cited by 7
“There is evidence from studies performed in patients with septic shock having hemodynamic characteristics similar to those seen in patients with ACLF that strongly supports norepinephrine as the preferred vasopressor [39].”
BackgroundVasopressor Therapy in Septic Shock
Lopa, A. J., Bhattacharjee, S., Mishra, R. C., Ahmed, A., & Sinha, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00011-0 · Cited by 4
Chou, H.-C., Huang, H., Chen, C.-Y., Wang, C.-L., Shu, C., Hsu, N., Lin, Y., Chen, J., & Sheng, W. (2018) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909117754040 · Cited by 3
Lü, X., Xu, X., & Wu, Y. (2021) · Pteridines · doi:10.1515/pteridines-2021-0002 · Cited by 3
Clinical update on COVID-19 for the emergency clinician: Airway and resuscitation
Chavez, S., Brady, W. J., Gottlieb, M. A., Carius, B. M., Liang, S. Y., Koyfman, A., & Long, B. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.05.011 · Cited by 3
“Norepinephrine is the first-line vasopressor due to its ability to increaseMAPwith fewer adverse effects such as arrhythmias and lower all-cause mortality in septic shock compared to other pressors, including dopamine [6-8,15].”
Froehlich, M., Koizumi, N., James, R. M., Christian, A. G. W., Choubey, A. P., Patel, S. K., Ortíz, J., & Siskind, E. J. (2022) · Pancreas · doi:10.1097/mpa.0000000000002103 · Cited by 3
“The mechanism is still a point of speculation but hypothesized to allow chronically overstimulated beta cells to replenish their insulin pool with recovery α glucokinase, an important enzyme linked to beta cell apoptosis.(15,17) Our analysis demonstrates decreased graft failure when vasopressors that stimulate the αad…”
BackgroundKanjee, Z., Berg, K. M., Bell, T. D., & Reynolds, E. E. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3385 · Cited by 4
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rodriguez-Leal, C., González‐Corralejo, C., Candel, F. J., & Salavert, M. (2024) · Revista Española de Quimioterapia · doi:10.37201/req/018.2024 · Cited by 10
“There is strong evidence against use of dopamine in septic shock because it is associated with higher mortality and risk of arrhythmias [209].”
BackgroundIdentification and Management of Sepsis in the Interventional Radiology Patient
Murtha, J. A., Khanna, V., Sasson, T., & Butani, D. (2017) · American Journal of Interventional Radiology · doi:10.25259/ajir-1-2017 · Cited by 4
Jönsson, S., Melville, J. M., Becirovic‐Agic, M., & Hultström, M. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00095.2018 · Cited by 3
“Hypotension during major surgery is managed with fluid resuscitation and vasopressors, such as norepinephrine (NE) (3).”
BackgroundSepsis and Common Infections in Interventional Radiology
Chlorogiannis, D., & Epelboym, Y. (2025) · Techniques in vascular and interventional radiology · doi:10.1016/j.tvir.2025.101041 · Cited by 2
Singh, R., Bandyopadhyay, T., & Maria, A. (2025) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmaf045 · Cited by 2
Management of post-resuscitation vasoplegic shock: targets, strategies and outcomes
Jendoubi, A., de Roux, Q., Cariou, A., Taccone, F. S., Ghaleh, B., Tissier, R., Kohlhauer, M., & Mongardon, N. (2025) · Critical Care · doi:10.1186/s13054-025-05794-w · Cited by 3
“In septic shock, a systemic review and meta-analysis of 11 trials comparing norepinephrine and dopamine confirmed that norepinephrine was associated with reduced all-cause mortality (RR: 0.89, 95% CI 0.81–0.98) and lower risk of cardiac arrhythmias [64].”
InfluentialCaballero, G. A. C. (2025) · ACTAS PERUANAS DE ANESTESIOLOGIA · doi:10.65016/m8grzd49 · Cited by 2
Kalamar, Ž., Landoni, G., Gorenjak, M., Cestar, I., Fluher, J., Horvat, M., Jerenec, K., Kit, B., Marinšek, M., Puklavec, N., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06323-z · Cited by 2
“Norepinephrine is considered the vaso-pressor of first choice and is superior to dopamine [1, 2].”
Quế, A. T., Dương, Đ. C., Nguyễn, L. Á. V., Phạm, T. H. G., & Trần, A. Đ. (2021) · Tạp chí Truyền nhiễm Việt Nam · doi:10.59873/vjid.v3i35.119 · Cited by 2
Leong, T. D. D., Mpofu, R., Dadan, S., Cohen, K., Dawood, H., Kredo, T., Parrish, A., Blockman, M., & Gopalan, P. (2025) · African Journal of Emergency Medicine · doi:10.1016/j.afjem.2025.05.005 · Cited by 3
“While these findings are consistent with previous meta-analyses [32, 33], the similar risks for mortality and dysrhythmia are in contrast with the strong recommendation provided in the 2021 SSC guidelines for noradrenaline as first-line therapy, despite their assessment of the quality of available…”
Lessons from the ICU: Choosing the Right Vasopressor
Fiorini, F., Antcliffe, D. B., & Gordon, A. C. (2019) · Lessons from the ICU · doi:10.1007/978-3-319-69269-2_30 · Cited by 2
Ji, J., & Brown, D. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00021-7 · Cited by 2
Agentes vasoactivos en sepsis: revisión crítica de la literatura
Correa, J. E. B., Carrillo, V. P., Rondón-Carvajal, J., & Laserna, A. (2023) · Universitas Médica · doi:10.11144/javeriana.umed64-2.seps · Cited by 2
Clinical Use of Adrenergic Receptor Ligands in Acute Care Settings
Langnas, E. M., & Maze, M. (2024) · Handbook of experimental pharmacology · doi:10.1007/164_2023_705 · Cited by 2
Fármacos vasoactivos en el tratamiento del shock séptico
Andaluz‐Ojeda, D., Cantón‐Bulnes, M. L., Richter, C. P., & Garnacho‐Montero, J. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.03.007 · Cited by 5
Vasoaktive Substanzen im septischen Schock – individualisierte Strategien
Lehner, G. F., Mayerhöfer, T., Perschinka, F., Benda, B., & Joannidis, M. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01272-x · Cited by 3
Methylene Blue in Septic Shock: Emerging Evidence, Clinical Applications, and Future Directions
Maheshwari, N., Malkania, B., & Mudiyanselage, R. (2025) · Cureus · doi:10.7759/cureus.86701 · Cited by 3
Pediatric Sepsis: Clinical Considerations
Balázs, G., Szima, S., Elek, N., & Dahlem, P. (2017) · Journal of Child Science · doi:10.1055/s-0037-1603897 · Cited by 2
Initial septic shock therapy in obstetrics (clinical guidelines)
Kulikov, A. V., Shifman, E. M., Николаевич, П. Д., Щеголев, А. В., Adamyan, L. V., Artymuk, N. V., Belokrinitskaya, T. E., Zabolotskikh, I. B., Ovezov, A. M., Ronenson, A. M., et al. (2019) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology20190515 · Cited by 2
Aoki, Y., Nakajima, M., Sugimura, S., Suzuki, Y., Makino, H., Obata, Y., Doi, M., & Nakajima, Y. (2023) · Korean Journal of Anesthesiology · doi:10.4097/kja.22805 · Cited by 2
“As numerous reports have shown that norepinephrine is less arrhythmogenic than dopamine in septic and cardiogenic shock, the shorter ICU stay may be attributable to arrhythmia management [10,13,26].”
PREDICTIVE VALUES OF PRESEPSIN AND C-REACTIVE PROTEIN ON PROGNOSIS IN SEVERE BURNS
Nițescu, B. (2023) · FARMACIA · doi:10.31925/farmacia.2023.3.8 · Cited by 3
Inotropes and Vasoactive Agents: Differences Between Europe and the United States
Beersel, D. V., & Rex, S. (2019) · Current anesthesiology reports · doi:10.1007/s40140-019-00323-2 · Cited by 3
HIV-positive patients in the intensive care unit
Parker, A., Lahri, S., Taljaard, J., & Koegelenberg, C. F. N. (2017) · South African Medical Journal · doi:10.7196/samj.2017.v107i11.12907 · Cited by 2
Metadata
- Authors
- Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A.
- Affiliations
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Avni, Tomer
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-03
- Volume
- 10
- Issue
- 8
- Pages
- e0129305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4523170
- OpenAlex
- W1630391490
- Cited by
- 293
- References
- 48
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 33 · 2023: 26 · 2022: 29 · 2021: 37 · 2020: 30 · 2019: 34 · 2018: 29 · 2017: 17 · 2016: 11 · 2015: 3
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Keywords
- septic shock, vasopressors, norepinephrine, dopamine, phenylephrine, epinephrine, vasopressin, terlipressin, all-cause mortality, hemodynamic outcomes, cardiac arrhythmias, blood lactate
- MeSH terms
- Terlipressin, Epinephrine, Hemodynamics, Humans, Lypressin, Norepinephrine, Phenylephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.